Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors

J Med Chem. 2010 Feb 25;53(4):1473-82. doi: 10.1021/jm901476x.

Abstract

On the basis of our understanding on the binding interactions of the benzothiophene template within the FIXa active site by X-ray crystallography and molecular modeling studies, we developed our SAR strategy by targeting the 4-position of the template to access the S1 beta and S2-S4 sites. A number of highly selective and potent factor Xa (FXa) and FIXa inhibitors were identified by simple switch of functional groups with conformational changes toward the S2-S4 sites.

MeSH terms

  • Animals
  • Carbamates / chemical synthesis
  • Carbamates / chemistry
  • Carbamates / pharmacokinetics
  • Crystallography, X-Ray
  • Drug Design
  • Factor IXa / antagonists & inhibitors*
  • Factor IXa / chemistry
  • Hydrogen Bonding
  • Models, Molecular
  • Molecular Conformation
  • Protein Binding
  • Rats
  • Rats, Sprague-Dawley
  • Stereoisomerism
  • Structure-Activity Relationship
  • Thiophenes / chemical synthesis*
  • Thiophenes / chemistry
  • Thiophenes / pharmacokinetics

Substances

  • Carbamates
  • Thiophenes
  • benzothiophene
  • Factor IXa

Associated data

  • PDB/3LC5